During the past decade, Nagoya Ekisaikai Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nagoya Ekisaikai Hospital" #1 sponsor was "Chugai Pharmaceutical" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 2 trials sponsored, "AstraZeneca" with 1 trials sponsored and "Bayer" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nagoya Ekisaikai Hospital" #1 collaborator was "Japan Lung Cancer Society" with 2 trials as a collaborator, "Tokyo Medical and Dental University" with 2 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Population Health Research Institute" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Nagoya Ekisaikai Hospital" are "Alzheimer Disease" (3 trials), "Colorectal Cancer" (2 trials), "Acute Non-cardioembolic Ischemic Stroke" (1 trials), "Alzheimer's Disease" (1 trials) and "Complicated Intra-abdominal Infection" (1 trials). Many other conditions were trialed in "Nagoya Ekisaikai Hospital" in a lesser frequency.

Most popular intervention types in "Nagoya Ekisaikai Hospital" are "Drug" (8 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Gantenerumab" (2 trials), "UFT adjuvant chemotherapy" (2 trials), "BAY2433334" (1 trials) and "BAY2433334 matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nagoya Ekisaikai Hospital" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Nagoya Ekisaikai Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Nagoya Ekisaikai Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Nagoya Ekisaikai Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".